Hanwen Wang

As a Ph.D. candidate in Biomedical Engineering at Johns Hopkins University, I focus on quantitative systems pharmacology modeling in immune-oncology and conducting in silico virtual clinical trials of immunotherapies and chemotherapies in triple-negative breast cancer.